Susan M Schlenner (Susan Schlenner)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 15

Top Topics

Inflammatory Response

Regulatory T Cells

Top Venues

Cancer immunology, immunotherapy : CII

Science advances

The Journal of experimental medicine

Genes and immunity

This page only lists publications with an associated author ORCID identifier.

Publications

Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Isaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, Raquel S Laureano, Jannes Govaerts, Rosa Trotta, Samantha Pretto, Shikang Zhao, Sarah Trusso Cafarello, Joren Verelst, Maarten Jacquemyn, Martyna Pociupany, Louis Boon, Susan M Schlenner, Sabine Tejpar, Dirk Daelemans, Massimilliano Mazzone, Abhishek Dinkarnath Garg
Targeting conserved TIM3 + VISTA + tumor-associated macrophages overcomes resistance to cancer immunotherapy. Science advances 10 (29) (2024)
Isaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, Raquel S Laureano, Jannes Govaerts, Rosa Trotta, Samantha Pretto, Shikang Zhao, Sarah Trusso Cafarello, Joren Verelst, Maarten Jacquemyn, Martyna Pociupany, Louis Boon, Susan M Schlenner, Sabine Tejpar, Dirk Daelemans, Massimilliano Mazzone, Abhishek Dinkarnath Garg
Targeting conserved TIM3 + VISTA + tumor-associated macrophages overcomes resistance to cancer immunotherapy. Science advances 10 (29) (2024)
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Isaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, Raquel S Laureano, Jannes Govaerts, Rosa Trotta, Samantha Pretto, Shikang Zhao, Sarah Trusso Cafarello, Joren Verelst, Maarten Jacquemyn, Martyna Pociupany, Louis Boon, Susan M Schlenner, Sabine Tejpar, Dirk Daelemans, Massimilliano Mazzone, Abhishek Dinkarnath Garg
Targeting conserved TIM3 + VISTA + tumor-associated macrophages overcomes resistance to cancer immunotherapy. Science advances 10 (29) (2024)
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Sotiria Pinioti, Himal Sharma, Nina C Flerin, Qian Yu, Amalia Tzoumpa, Sarah Trusso Cafarello, Elien De Bousser, Nico Callewaert, Guillaume Oldenhove, Susan M Schlenner, Bernard Thienpont, Abhishek Dinkarnath Garg, Mario Di Matteo, Massimilliano Mazzone
A metabolic gene survey pinpoints fucosylation as a key pathway underlying the suppressive function of regulatory T cells in cancer. Cancer immunology research (2023)
Valentina Lykhopiy, Vanshika Malviya, Stephanie Humblet-Baron, Susan M Schlenner
"IL-2 immunotherapy for targeting regulatory T cells in autoimmunity". Genes and immunity (2023)
Steffie Junius, Adamantios V Mavrogiannis, Pierre Lemaitre, Margaux Gerbaux, Frederik Staels, Vanshika Malviya, Oliver T Burton, Václav Gergelits, Kailash Singh, Raul Yhossef Tito Tadeo, Jeroen Raes, Stephanie Humblet-Baron, Adrian Liston, Susan M Schlenner
Unstable regulatory T cells, enriched for naïve and Nrp1neg cells, are purged after fate challenge. Science immunology 6 (61) (2022)
Vanshika Malviya, Lidia Yshii, Steffie Junius, Abhishek D Garg, Stephanie Humblet-Baron, Susan M Schlenner
Regulatory T cell stability and functional plasticity in health and disease. Immunology and cell biology (2022)
Carly E Whyte, Kailash Singh, Oliver T Burton, Meryem Aloulou, Lubna Kouser, Rafael Valente Veiga, Amy Dashwood, Hanneke Okkenhaug, Samira Benadda, Alena Moudra, Orian Bricard, Stephanie Lienart, Pascal Bielefeld, Carlos P Roca, Francisco José Naranjo-Galindo, Félix Lombard-Vadnais, Steffie Junius, David Bending, Masahiro Ono, Tino Hochepied, Timotheus Y F Halim, Susan M Schlenner, Sylvie Lesage, James Dooley, Adrian Liston
Context-dependent effects of IL-2 rewire immunity into distinct cellular circuits. The Journal of experimental medicine 219 (7) (2022)